Ji Ho Kim
Papers
1
Total Citations
3
H-Index
1
About
Dr. Ji Ho Kim is a leading anesthesiologist and clinical researcher whose work focuses on the pharmacodynamics of sedative agents, particularly remimazolam, and the critical influence of patient-specific factors such as sex on anesthetic dosing. In his landmark 2024 study, *"The influence of sex on the dosage of remimazolam co-administered with remifentanil for loss of consciousness in adult patients,"* Dr. Kim employed a rigorous Dixon's up-and-down sequential allocation trial to determine the 50% effective dose (ED50) of remimazolam for loss of consciousness, revealing significant between-sex differences in required dosages. This work provides essential, actionable data for personalized anesthesia, directly challenging one-size-fits-all dosing protocols. Though recently published, the study has already garnered 3 citations, underscoring its immediate relevance to clinical practice and perioperative medicine. Dr. Kim’s contributions are pivotal for advancing safe, tailored sedation strategies, making him a key voice in the evolving field of sex-based pharmacodynamics in anesthesia.
Research Focus
Key Achievements
Top Papers
- 1